Valeant Pharmaceuticals North Am
Valeant Pharmaceuticals North Am appears in FDA public data with 1 recall, 0 510(k) clearances, 0 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-020-2014, Class III) was initiated on September 20, 2013.
Summary
- Total Recalls
- 1
- 510(k) Clearances
- 0
- Inspections
- 0
- Compliance Actions
- 0
Recent Recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-020-2014 | Class III | Acanya (Clindamycin Phosphate and Benzoyl Peroxide) Gel 1.2% and 2.5%, Net Wt. 3.5 g, Rx Only, Sampl | September 20, 2013 |